Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled time : 04:00 save search
Shareholders approve long-delayed merger between B-D aggregator Wentworth and SPAC – Citywire
Published: 2024-03-11 (Crawled : 04:00) - spacfeed.com
ATMU A | $30.87 -0.71% 0.0% 2M
|
n/a
|
| O: -1.89%
H: 6.83%
C: 4.91%
V | News | $269.78 -0.59% -0.57% 7.8M
|
Finance
|
| O: -0.21%
H: 0.47%
C: 0.4%
spac
Trump-Tied SPAC Jumps on Gaining Long-Awaited SEC Approval – Yahoo Finance
Published: 2024-02-15 (Crawled : 04:00) - spacfeed.com
SCRM S | $10.795 0.23% 0.23% 3.3M
|
n/a
|
| O: 0.09%
H: 0.0%
C: 0.0%
approval spac
Standard BioTools Stockholders Approve Merger with SomaLogic
Published: 2024-01-05 (Crawled : 04:00) - globenewswire.com
LAB | $2.515 -0.98% -0.99% 2.7M
|
Manufacturing
|
| O: 3.63%
H: 1.75%
C: -6.5%
SLGC | $2.1 -4.76% 34M
|
|
| O: -2.23%
H: 0.0%
C: 0.0%
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
Published: 2023-11-17 (Crawled : 04:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 1.38%
H: 1.79%
C: 1.79%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.5%
H: 0.3%
C: 0.0%
xtandi fda approved cancer treatment
mCloud Special Committee Approves New Corporate Structure to Maximize Value from Exploration of Strategic Alternatives
Published: 2023-08-22 (Crawled : 04:00) - prnewswire.com
MCLD | $0.111 -18.02% 1.1M
|
n/a
|
| O: -2.83%
H: 9.09%
C: 4.0%
Ecopetrol S.A. obtains approval for a credit loan with international banks for up to US$ 400 million
Published: 2023-05-12 (Crawled : 04:00) - prnewswire.com
EC | News | $11.51 1.5% -0.09% 1.4M
|
Energy Minerals
|
| O: 0.55%
H: 1.74%
C: 1.42%
approval international
ShoulderUp Technology Acquisition Corp. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement – Yahoo Finance
Published: 2023-04-26 (Crawled : 04:00) - spacfeed.com
SUAC | $10.98 3.59% -2.55% 27K
|
|
| O: 0.0%
H: 1.44%
C: -0.38%
BFI | $0.4215 2.81% 2.73% 130K
|
|
| O: 1.94%
H: 0.0%
C: -4.76%
BY 4 | $20.72 3.19% 0.0% 93K
|
Finance
|
| O: 0.05%
H: 2.36%
C: 0.84%
management approval acquisition extension technology trust agreement
Ionis accounces FDA advisory committee voted unanimously for a potential accelerated approval of tofersen for SOD1-ALS
Published: 2023-03-23 (Crawled : 04:00) - prnewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 3.63%
H: 0.0%
C: -8.07%
fda approval potential
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
Published: 2023-01-19 (Crawled : 04:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.26%
H: 1.19%
C: 1.19%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.1%
H: 0.97%
C: -0.37%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
drug approved
MAVERIX RECEIVES COURT APPROVAL FOR ARRANGEMENT WITH TRIPLE FLAG PRECIOUS METALS CORP.
Published: 2023-01-18 (Crawled : 04:00) - prnewswire.com
MMX | $4.86 2.88% 0
|
Non-Energy Minerals
|
| O: 0.61%
H: 0.0%
C: 0.0%
approval
Neurologic Disorders Therapeutics Market Size to Grow by USD 33.46 billion, Approval Of Novel Drugs to Boost Market Growth - Technavio
Published: 2022-08-03 (Crawled : 04:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.8%
H: 0.2%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.6%
H: 0.0%
C: -0.76%
NPCE S | $13.78 -1.57% -1.6% 96K
|
Manufacturing
|
| O: 0.52%
H: 3.71%
C: -2.93%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.11%
H: 0.31%
C: -0.34%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.29%
H: 0.24%
C: -0.58%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.17%
H: 0.12%
C: -1.29%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.41%
H: 3.35%
C: 1.71%
ACAD | $16.82 -1.47% -1.49% 3.5M
|
Health Technology
|
| O: 2.47%
H: 2.8%
C: -2.67%
approval therapeutics growth market
Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer
Published: 2022-06-10 (Crawled : 04:00) - prnewswire.com
GILD | News | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -2.99%
H: 0.0%
C: 0.0%
trodelvy approval china cancer breast cancer
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
Published: 2021-07-29 (Crawled : 04:00) - prnewswire.com
VTRS | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 2.88%
H: 0.27%
C: -2.39%
diabetes treatment injection insulin approval biosimilar glargine
Brookfield Infrastructure Partners Submits Written Consent to the TSX as Evidence of Brookfield Infrastructure Corporation Security Holder Approval of the Inter Pipeline Ltd. Offer and Share Issuance
Published: 2021-07-27 (Crawled : 04:00) - globenewswire.com
BIP | $27.16 3.35% 0.0% 470K
|
Utilities
|
| O: -0.07%
H: 0.35%
C: -0.86%
BIPC | $30.87 3.21% 0.0% 740K
|
Utilities
|
| O: -0.32%
H: 0.06%
C: -1.66%
security approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.